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Introduction
Adenosine (ADO) is an abundant endogenous neuromodulator, with a generally
suppressive effect on excitatory synaptic transmission. It is a metabolite of adenosine
triphosphate (ATP), hence its ubiquitous presence in the central nervous system. Due in
part to its role as a cellular energy molecule, adenosine finds its way into regulating key
functions in the brain during both non-pathological and pathological states. In particular,
the A1 adenosine receptor subtype has the unique role of inhibiting synaptic
transmission both pre and postsynaptically. Much attention has been focused on the
role of adenosine in modulating specific excitatory glutamatergic channels, alphaamino-3-hydroxyl-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-aspartate
(NMDA). The heterogeneity of adenosine receptors and their sometimes opposing
affects on excitatory transmission has made the exact role of adenosine complex. Part
of the excitement around adenosine is created by a desire to understand how NMDA
receptors are modulated by it. Previous research has shown that in different brain
structures adenosine may have heterogeneous effects on the balance of NMDA
receptor and non-NMDA receptor-mediated currents. In pyramidal neurons of the
hippocampus, adenosine proportionally reduced the NMDA and non-NMDA mediated
excitatory currents (Garaschuk, Kovalchuk, & Krishtal, 1992), whereas in dopaminergic
neurons of rat midbrain, adenosine preferentially reduced NMDA currents (Y.-N. Wu,
Shen, & Johnson, 1999), thus leading to a decreased ratio of NMDA/non-NMDA
currents. It is known that in layer 2/3 pyramidal neurons of rat visual cortex, adenosine
suppresses excitatory synaptic transmission (N. Bannon, Zhang, Ilin, Chistiakova, &
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Volgushev, 2014). However, it remains unknown whether adenosine has the same
effect on NMDA and AMPA-mediated currents. Here we asked whether NMDAmediated currents are suppressed by adenosine differentially from AMPA-mediated
currents, or whether the NMDA/AMPA balance is maintained in synaptic responses of
layer 2/3 pyramidal neurons during application of adenosine.
To test this, we conducted in vitro whole-cell recordings from layer 2/3 pyramidal
neurons in slices from rat visual cortex and, studied synaptic currents evoked with
stimulating electrodes located in layer 4. Mixed excitatory postsynaptic currents
composed of AMPA and NMDA-mediated components were recorded on the
background of blockade of inhibition by 2-100µM picrotoxin (PTX). The identity of AMPA
and NMDA currents was confirmed pharmacologically using selective antagonists
DNQX and APV. Application of adenosine (20µM) led to a proportional decrease of
NMDA and AMPA mediated currents, so that their balance in compound responses was
maintained. These results were confirmed with recording of isolated NMDA currents
and isolated AMPA currents, which showed a similar reduction in amplitude. Thus, in
synaptic inputs to layer 2/3 pyramidal neurons of rat visual cortex, adenosine reduces
the amplitude of NMDA and AMPA-mediated currents proportionally.
Adenosine at the synapse
In order to appreciate the larger consequences of adenosine modulation it is
important to consider how adenosine is introduced to the synapse. Vesicular release of
neurotransmitters such as acetylcholine, norepinephrine, and 5-HT is often
accompanied by adenine nucleotides (Dunwiddie, Diao, & Proctor, 1997; Silinsky,
1975), and activation of adenylyl cyclase leads to diffusion of cAMP into the
2

extracellular space (Rosenberg & Li, 1995). Both sources of adenine nucleotides are
metabolized from their precursors to adenosine monophosphate (AMP) and
subsequently to the purine adenosine by 5’-nucleotidase in a rate-limiting step
(Dunwiddie et al., 1997). An additional source of adenosine at the synapse may also be
generated during times of high energy demand when the cell metabolizes ATP. Since
the intracellular concentrations of ATP are in the millimolar range (approx. 3 mM) and
AMP in the nanomolar, a relatively small amount of ATP must be metabolized to create
a significant increase in AMP concentration (R.A. Cunha, 2001; Rodrigo A. Cunha,
2008; Dunwiddie & Masino, 2001). Intracellular AMP is then converted into adenosine
via 5’-nucleotidase—an opposing reaction with adenosine kinase (Decking, Schlieper,
Kroll, & Schrader, 1997; Kroll, Decking, Dreikorn, & Schrader, 1993). In an alternative
pathway adenosine is generated by a transmethylation reaction where Sadenosylhomocysteine hydrolase converts S-adenosylhomocysteine into adenosine
and homocysteine. Once sufficient concentrations of adenosine accumulate within the
cell it may flow via facilitated diffusion to the extracellular space through nucleoside
transporters (Dunwiddie & Masino, 2001).
In the hippocampus, it has been reported that astrocytes may also contribute to
an increase in extracellular adenosine (Pascual et al., 2005). Gliotransmission begins
with activation of astrocytic receptors by neurotransmitters, which cause an increase of
intracellular Ca2+ leading to release of ATP into the extracellular space (Halassa, Fellin,
& Haydon, 2007). Once in the extracellular space, ATP is quickly metabolized to
adenosine by ecto-nucleotidases.
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Despite the variety of ways adenosine is introduced to the synapse there exists a
common theme, that is—adenosine release is activity-dependent. In a study conducted
by Pajski and Venton (2013), they demonstrated an activity-dependent release of
adenosine following extracellular stimulation in caudate-putamen, nucleus accumbens,
hippocampus, and cortex. This was corroborated by introduction of a Ca2+chelator or
tetrodotoxin that nearly abolished adenosine release (Pajski & Venton, 2013). The local
concentrations of adenosine also varied depending on brain region with the caudateputamen having the highest concentrations (0.34 M) and the secondary motor cortex
the lowest (0.06M). The extracellular breakdown of ATP following vesicular release
was the primary mechanism of adenosine formation in nucleus accumbens,
hippocampus, and prefrontal cortex whereas adenosine in the caudate-putamen was
glutamate-receptor dependent. The differing sources and concentrations of adenosine
by brain regions highlights that adenosine may have differential effects on synaptic
transmission in differing brain regions.
The clearance of adenosine from the extraceullar space can be accomplished by
two prevailing mechanisms. Adenosine can be degraded at the synapse into its inert
form inosine by adenosine deaminase. However, under non-energetically demanding
circumstances intracellular concentrations of adenosine favor diffusion into the cell
where adenosine kinase captures it by phosphorylation. The latter mechanism is
thought to play a larger role in clearing adenosine from the synapse as adenosine
deaminase antagonism has little effect on extracellular adenosine concentration
(Dunwiddie & Masino, 2001; Lloyd & Fredholm, 1995; Pak, Haas, Decking, & Schrader,
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1994). This result makes intuitive sense due to the concentration gradient favoring
adenosine flowing into the cell from the extracellular space.

Adenosine Receptors (A1, A2A, A2B, A3)
Currently, there are four adenosine receptors (A1R, A2AR, A2BR, A3R) that have
been isolated and cloned in variety of species including human (Olah & Stiles, 1995).
Each adenosine receptor is part of the G-protein coupled receptor family (Dunwiddie &
Masino, 2001; Olah & Stiles, 1995). The functions of each receptor depend on both their
location at the synapse (pre- or postsynaptic) and their effects on intracellular targets.
The A1R is the most widely expressed adenosine receptor in all regions of the
brain (Dixon, Gubitz, Sirinathsinghji, Richardson, & Freeman, 1996). The most common
function of the A1 receptor is the reduction in vesicular release probability by reducing
calcium influx into the presynaptic terminal through N-type Ca2+ channels (Gomes,
Kaster, Tomé, Agostinho, & Cunha, 2011; Gundlfinger et al., 2007; L.-G. Wu & Saggau,
1994, 1997). There may also be an effect of presynaptic A1R agonism downstream of
Ca2+ influx that reduce release probability but the mechanisms are unclear (Yawo &
Chuhma, 1993). However, the net effect of presynaptic A1R activation appears to be the
reduction in release of glutamate, aspartate, acetylcholine, and serotonin (Corradetti, Lo
Conte, Moroni, Beatrice Passani, & Pepeu, 1984; Fontanez & Porter, 2006; Lupica,
Proctor, & Dunwiddie, 1992; Silinsky, 1984). It has also been demonstrated that A1R
activation can reduce GABAergic inhibitory transmission in the neocortex (Kirmse,
Dvorzhak, Grantyn, & Kirischuk, 2008; Zhang, Bannon, Ilin, Volgushev, & Chistiakova,
2015). Postsynaptic A1 receptors affect synaptic transmission in both cortical and
5

subcortical brain regions (Kim & Johnston, 2015; Takigawa & Alzheimer, 1999; L. O.
Trussell & Jackson, 1985). Post-synaptic A1 receptors act on G-protein coupled inwardly
rectifying potassium channels (GIRKs) causing a hyperpolarization of the membrane—
making the neuron less excitable (Thompson, Haas, & Gähwiler, 1992; L. Trussell &
Jackson, 1987; L. O. Trussell & Jackson, 1985). Thus, the main action of the A1R is to
suppress excitatory synaptic transmission regardless of its location pre- or postsynaptic.
The A2A receptor opposes the suppressive effects of the A1 receptor which may
allow for a dynamic tuning of synapses. However, compared to the A1 receptor the A2A
receptor is not widely distributed but is found in high concentrations in the basal ganglia
and low concentrations in other brain areas like cortex (Rodrigo A. Cunha, 2005). In
addition, the A2A receptors in the basal ganglia are largely postsynaptic where they may
depolarize neurons (Rodrigo A. Cunha, 2005). In the hippocampus, postsynaptic A2A
receptors activated by the selective agonist CGS 21680 slowly depolarized the
membrane and increased the amplitude of evoked excitatory post synaptic potentials
(H. Li & Henry, 1998). However, presynaptic A2A receptors facilitate the release of
neurotransmitters such as glutamate, GABA, glycine, acetylcholine, noradrenaline, and
serotonin (Rodrigo A. Cunha, 2005). The co-localization of A1 and A2A receptors in the
hippocampus and striatum suggests there may be a tuning of glutamatergic synapses
between the inhibitory A1Rs and facilitating A2ARs (Rodrigo A. Cunha, 2005; Rebola,
Rodrigues, et al., 2005). This effect may be achieved by presynaptic A1R-A2AR
heteromers where A2A agonism can decrease the affinity of the A1R for adenosine
(Luísa V. Lopes, Cunha, & Ribeiro, 1999; L.V. Lopes, Cunha, Kull, Fredholm, & Ribeiro,
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2002). This effect on excitatory synaptic transmission highlights the potential for a
dynamic relationship between the A1 and A2A receptors pre and postsynaptically.
The A2B receptor has been found in all tissues of the central nervous system by
in situ hybridization (Dixon et al., 1996; Feoktistov & Biaggioni, 1997). However, the
function of the A2B receptor is unclear, it has been characterized as a low affinity
receptor (Feoktistov & Biaggioni, 1997) which makes studying the physiological
implications of A2BR agonism difficult. Similar to the A2A receptor, A2BR activation
converge on stimulation of adenyl cyclase but only A2B agonism leads to the activation
of phospholipase C. The consequence of this difference is still under debate but A 2B
receptors are thought to function similar to A2A in that they facilitate excitatory synaptic
transmission by an increase of presynaptic Ca2+ influx at terminals (Feoktistov &
Biaggioni, 1997). In all likelihood, the A2B receptor is not a key player under normal
physiological conditions but rather when adenosine tone increases dramatically during
pathological states such as ischemia or trauma.
The A3 receptor has been identified in many brain tissues of the central nervous
system but had lower concentrations in the cortex as compared to subcortical structures
(striatum, nucleus accumbens, olfactory bulb, hippocampus, cerebellum, hypothalamus,
and thalamus; Dixon et al., 1996). Similar to the A2BR, the A3 receptor is a low affinity
adenosine receptor (Luísa V. Lopes et al., 2003). The A3 receptor is the most poorly
understood adenosine receptor and likely only serves a function during
pathophysiological states (Gessi et al., 2008). Most of the effects of adenosine as a
neuromodulator can be attributed to the actions of the A1R in most brain areas and A2AR
in the basal ganaglia.
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Adenosine in normal physiology
While adenosine may act first at the molecular and synaptic level it is important
to consider the broader implications adenosine has on normal physiological
phenomena. Adenosine has long been studied in the context of arousal or neuronal
excitability, the sleep/wake cycle, and its role in neuroprotection. In addition, it should be
mentioned that while adenosine is ubiquitous in the central nervous system it modulates
the activity of brain regions differently due to both their intrinsic differences in structure
and adenosine receptor distributions. In the section that follows the heterogeneity of
adenosine’s actions in specific brain regions will be highlighted.
Sleep
Perhaps the most familiar way to modulate the normal role of adenosine is
through caffeine, a mild stimulant frequently consumed to promote arousal and
wakefulness. When consumed, caffeine acts as a non-selective adenosine antagonist
which likely has an affect on A1 and A2A receptors leading to an increase in neuron
excitation (Bjorness & Greene, 2009; Ferre et al., 2008). As one may expect, the
opposing affect of adenosine agonists is to promote sleep behavior (Bjorness & Greene,
2009). Thus, it makes intuitive sense that adenosine levels rise during the day to
promote sleep behavior and decrease during sleep. However, this simplified model of
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sleep falls short of its true complexity due to the functional differences between brain
areas.
In the mesopontine tegmentum, adenosine inhibits neurons in the cholinergic
arousal system by reducing evoked EPSCs and GABAergic IPSCs. This reduction in
glutamatergic, cholinergic, and GABAergic synaptic transmission promotes sleep
behavior and influences thalamocortical neural activity characteristic of slow wave sleep
(Bjorness & Greene, 2009; Rainnie, Grunze, McCarley, & Greene, 1994). The A1
receptor is thought to mediate slow wave activation via the interaction between the brain
stem and thalamocortical neurons. Under an increased adenosine tone, thalamic and
cortical neurons have increased GIRK channel conductance and relatively less activity
due to A1R presynaptic inhibition (Bjorness & Greene, 2009). The end result of this
modulation is a switch from a tonic firing to burst firing pattern of thalamocortical
neurons; this firing pattern corresponds to delta waves seen on an EEG (Bjorness &
Greene, 2009; Halassa, 2011).
Another key player in sleep behavior is the basal forebrain. Much like the
mesopontine tegmentum, the basal forebrain contains cholinergic neurons responsible
for arousal which are more active during waking states or REM sleep. Adenosine
agonists perfused to the basal forebrain promote sleep behavior whereas antagonists
achieved the opposite effect (Bjorness & Greene, 2009; Strecker et al., 2000). In
addition, experiments involving sleep deprivation show increased adenosine tone in
cortex as well as basal forebrain. However, after prolonged deprivation adenosine tone
is only stable or increasing in basal forebrain (Bjorness & Greene, 2009). The
implications of this finding suggest that rising adenosine levels during waking periods
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reduce the activity of cholinergic and non-cholinergic neurons in the basal forebrain
which results in sleep behavior.
The preoptic/anterior hypothalamus (POAH) and ventrolateral preoptic area
(VLPO) have ‘sleep active’ neurons that preferentially fire during SWS. Interestingly,
these neurons are indirectly activated by adenosine via the presynaptic reduction of
GABAA release from inhibitory neurons onto the ‘sleep active’ neurons. Again, the net
effect of this disinhibition of GABAergic transmission is a transition from wake behavior
to SWS (Strecker et al., 2000).
Generally, adenosine’s role in the sleep/wake cycle is to reduce synaptic activity
through the activation of A1 receptors. However, this activation has different
consequences in different brain regions. Thalamocortical neurons experience a shift
between tonic and burst firing due to increased GIRK conductance and a reduction in
presynaptic release probability. Whereas hypothalamic ‘sleep active’ neurons are
disinhibited by presynaptic A1R activation. Also, the cholinergic and non-cholinergic
neurons responsible for arousal in mesopontine tegmentum and basal forebrain are
inhibited by rising adenosine tone. The ability of adenosine to modulate these vastly
different networks in such a concerted manner truly highlights its potential to influence
other phenomena in the central nervous system.
Neuroprotection
The function of adenosine as an endogenous neuroprotector stems from its role
in reducing excitatory synaptic transmission. As was stated before, during times of high
energetic demand a neuron will expend large amounts of ATP which lead to an increase
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of adenosine tone. This mechanism seems to be important in mitigating the damage
caused during epileptic seizures (During & Spencer, 1992) and other excitotoxic events.
Evidence of increased adenosine concentrations following ischemic or hypoxic events
have also been reported in both in vitro and in vivo studies. The following section will
highlight the function of adenosine as an endogenous neuroprotector during times when
a neural network may be stressed.
When considering the neuroprotecive role of adenosine, the A1 receptor
becomes the center of focus due to its role in dampening excitatory glutamatergic
transmission. Selective A1R agonists have been shown to reduce neuronal death in
experimentally induced hypoxia, ischemia, and epilepsy (Rodrigo A. Cunha, 2005; de
Mendonça, Sebastião, & Ribeiro, 2000). Conversely, selective A1R antagonists
exacerbate the damage caused by these pathologies. The exact mechanisms have yet
to be determined but likely reduce NMDA receptor activation by inhibiting glutamate
release at the synapse. However, adenosine receptors located in tissue outside the
CNS such as heart make clinical application of adenosine agonists dangerous; A1R
activation in heart causes bradycardia (Dunwiddie & Masino, 2001).
Although considerably less abundant than the A1R in healthy tissue, the A2A
receptor may provide a clinical target for treatments. The logic behind this argument
rests in a long-term downregulation of A1Rs and upregulation of A2ARs in tissue that is
chronically challenged with noxious stimuli such as epileptic seizures or ischemia
(Rodrigo A. Cunha, 2005; Rebola et al., 2003). The consequence of this ‘flipped’
adenosine receptor density is a shift from a tonic inhibitory effect of adenosine on
excitatory transmission to a facilitating. Interestingly, this phenomena was observed in
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the cerebral cortex where A2ARs are typically less concentrated (Rebola, Porciúncula, et
al., 2005). Multiple experiments have confirmed that A2A antagonists provide robust
neuroprotection when neurons are challenged with noxious stimuli (Rodrigo A. Cunha,
2005).
Astrocytes have become increasingly important in understanding the role of
adenosine during epileptic seizures. Evidence that astrocytes contribute to endogenous
adenosine tone comes from experiments with dominant negative mutation of soluble Nethylmaleimde-sensitive factor mice (dsSNARE-mice). In these mutants, astrocytes are
unable to release ATP normally because they lack the docking proteins required for
release; this caused a loss in tonic adenosine suppression (Pascual et al., 2005). Under
normal ATP release from astrocytes, ATP is rapidly metabolized to adenosine via
several ectonucleotidases. As was discussed above, the extracellular adenosine is
taken up by astrocytes and captured by adenosine kinase (ADK) thus changes in ADK
will dramatically effect adenosine tone (Boison, 2012). In the hippocampus, an in vitro
experiment demonstrated pharmacological blockade of ADK caused an increase in
synaptic adenosine which decreased glutamatergic excitatory synaptic transmission in
an A1R dependent fashion (Boison, 2012; Etherington et al., 2009). Seizure activity
induced by high frequency stimulation was significantly reduced under ADK inhibition.
However, the blockade of ADK did not effect activity-dependent release of adenosine
therefore the increase in adenosine is likely attributable ADK housed in astrocytes
(Boison, 2012; Etherington et al., 2009). Further evidence suggesting astrocytes role in
epilepsy comes from an in vivo study that induced mesial temporal lobe epilepsy
(MTLE) seizures by causing astrogliosis (an increase in astrocytes secondary to neuron
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death) and overexpression of ADK in CA3 region of the hippocampus and amygdala
(Boison, 2012).
Adenosine clearly has a role as a natural break on seizure activity. When the
neurons fire during a seizure there is an activity-dependent release of adenosine which
acts on A1Rs to reduce further excitation. In addition, astrocytes may release ATP to
increase local adenosine concentrations. However, it should be mentioned that much of
the research in epilepsy has been conducted in vitro and in subcortical structures; more
research is needed in order to elucidate adenosine’s role in seizures in the neocortex.
NMDA and AMPA Receptors
Excitatory synaptic transmission is mediated by four types of ionotropic
glutamate receptors, delta-, kainate, alpha-amino-3-hydroxyl-5-methyl-4isoxazolepropionic acid (AMPA), and N-methyl-D-aspartate (NMDA) receptors. The
latter two receptors, AMPA and NMDA, have been researched extensively for their roles
in synaptic transmission. The following section discusses the structure and function of
AMPA and NMDA receptors with an emphasis on the NMDA receptor due to its key role
as a detector of pre/post-synaptic activity and synaptic plasticity.
In general, ionotropic glutamate receptors are integral membrane proteins
composed of four subunits that form a channel in the membrane that allows the
passage of cations. The AMPA receptor is composed of four subunits (GluA1-GluA4)
which can form both homo- or heteromers. The NMDA receptor is composed of
combinations of homomers (two GluN1 with two GluN2 subunits or two GluN1 with one
GluN1 and GluN3). In addition to binding glutamate, NMDA receptors must bind glycine
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to open; the GluN1/GluN3 subunits bind glycine and GluN2 glutamate (Traynelis et al.,
2010). Functionally, the binding of glutamate is the true determinant of NMDAR
activation as tonic levels of glycine nearly saturate the co-activation site (Vyklicky et al.,
2014). Another functional caveat of the NMDAR is the variety of GluN2 subunits
(GluN2A, GluN2B, GluN2C, GluN2D) which have been the focus of recent research but
will not be mentioned further.
The selective ion permeability of AMPA and NMDA receptors is determined by a
three alpha helical transmembrane domain which creates a pore in the membrane. The
key difference between AMPA and NMDA receptors in this region is the residues in a
critical region of the pore known as the QRN site. In AMPA receptors, the QRN site has
a glutamine or arginine residue whereas the NMDAR has an asparagine residue
(Traynelis et al., 2010). One consequence of these residues is that AMPA and NMDA
receptors selectively pass cations such as Na+ and Ca2+. However, NMDA receptors are
three or four times more permeable to Ca2+ than calcium permeable AMPA receptors
(Traynelis et al., 2010). Another consequence of the residues in the NMDA pore is a
reduction of NMDAR activity at hyperpolarized potentials by a Mg2+ ion ‘stuck’ in the
channel (Mayer, Westbrook, & Guthrie, 1984; Nowak, Bregestovski, Ascher, Herbet, &
Prochiantz, 1984; Traynelis et al., 2010). This allows the NMDAR to act as a
coincidence detector of pre/postsynaptic activity; the NMDAR is only active during
postsynaptic depolarization and presynaptic release of glutamate (Mayer et al., 1984;
Nowak et al., 1984; Tabone & Ramaswami, 2012).
NMDAR-dependent Long Term Potentiation (LTP)/ Long Term Depression (LTD)
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It has been well established that the NMDA receptor is important in inducing long
term changes in synaptic transmission; a phenomenon known as plasticity. The classic
way to induce long-term potentiation (LTP) is by short (1-2 seconds), high frequency
(>20Hz) stimulation of fibers which in turn causes the postsynaptic cell to fire. When
postsynaptic NMDARs are activated during stimulation protocol, local Ca2+
concentration increases briefly (<2 seconds) which activates calcium/calmodulin
dependent-protein kinase II (CAMKII) (Bliss & Collingridge, 1993; Malenka & Bear,
2004). The net result of Ca2+ influx appears to be two-fold: the recruitment of additional
AMPARs and/or phosphorylation of AMPARs (Malenka & Bear, 2004). The effect of
this modification to the synapse will be a greater response to glutamate released at the
synapse over the course of hours, days or weeks.
In direct opposition of strengthening a synapse via LTP, a neuron must also have
the ability to weaken a synapse. Interestingly, the NMDAR plays a critical role in
inducing LTD as well as LTP. The induction of LTD is often accomplished
experimentally by low frequency stimulation (0.5-5 Hz) and a slight postsynaptic
depolarization to alleviate the Mg2+ ion blocking the NMDAR (Malenka & Bear, 2004).
When NMDA antagonists are used LTD does not occur (Dudek & Bear, 1992) but
experiments using NMDA itself as an agonist cause LTD (R. Li et al., 2004). The
mechanism also appears to require Ca2+ influx through the NMDA receptor as
experiments show uncaging of Ca2+ in dendritic spines causes LTD (Malenka & Bear,
2004). In contrast to LTP, the induction of LTD via increased Ca2+ in dendritic spines
occurs only when NMDARs are activated with low frequency stimulation. The specific
intracellular cascades have not been entirely worked out. However, there is evidence
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that suggests the dephosphorylation of protein kinase A (PKA) allows LTD to occur.
Furthermore, there is evidence that protein phosphatase 1 (PP1) acts on PKA to induce
LTD (Malenka & Bear, 2004). As one might expect, the consequence of LTD is a mirror
of LTP: AMPA receptor density declines in a clathrin/dynamin-dendent manner and are
dephosphorylated to reduce the probability of opening (Malenka & Bear, 2004).
The mechanisms of LTP and LTD discussed above are by no means exhaustive.
There exists other means by which a neuron may change the strength of its synapses
independent of the NMDA receptor. For instance, Shaffer collateral-CA1 synapses can
undergo LTD independent of NMDA receptor via metabotropic glutamate (mGlut)
receptors. Also, endogenous endocannabinoids released postsynaptically can activate
presynaptic CB1 receptors to depress excitatory synaptic transmission in cerebellum
and hippocampus (Malenka & Bear, 2004). However, it is clear from the abundant
research in NMDA-dependent LTP/LTD that it is a robust mechanism of plasticity.
Methods
All experimental procedures used in this study are in compliance with the US
National Institutes of Health regulations and were approved by the Institutional Animal
Care and Use Committee of the University of Connecticut. Slice preparation details
were similar to those used in previous studies (N. M. Bannon et al., 2016; N. Bannon et
al., 2014; Zhang et al., 2015). Male Wistar rats of postnatal age (P) 21-38 days were
decapitated under deep isoflurane anesthesia. The brain was quickly extracted, and
350 µm-thick coronal slices containing the visual cortex were prepared using a Leica
VT100S vibratome. The brain was constantly bathed in ice-cold oxygenated artificialcerebral spinal fluid (ACSF in mM: 125 NaCl, 25 NaHCO3, 25 glucose, 3 KCl, 1.25
16

NaH2PO4, 2 CaCl2, 1 MgCl2 bubbled with 95% O2/5% CO2, pH 7.4) during slice
preparation. Coronal slices were allowed to recover for at least 1h at room temperature.
Recordings were conducted by transferring slices to a recording chamber mounted on
an Olympus BX-50WI microscope equipped with infrared differential interference
contract (IR-DIC) optics. During recording, slices were submerged in oxygenated ACSF
at 30-32 C.

We made whole-cell recordings from visually and physiologically identified
pyramidal cells in layer 2/3 of the visual cortex using DIC microscopy. Identification of
pyramidal neurons was reliable as demonstrated in previous work with biocytin labeling
and morphological reconstruction of recorded neruons (M Volgushev, Vidyasagar,
Chistiakova, & Eysel, 2000). Intracellular pipette solution contained in mM: 130 KGluconate, 20 KCl, 10 HEPES, 10 Na-Phosphocreatine, 4 Mg-ATP, 0.3 Na2-GTP (pH
7.4 with KOH). All excitatory postsynaptic currents (EPSCs) were recorded in Layer 2/3
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and induced by a pair of stimulation electrodes (S1 and S2) in Layer 4 (Fig. 1).
Stimulation current intensities were tuned to evoke monosynaptic EPSCs in the
recorded neuron. Paired stimuli (50 ms interstimulus interval) were applied to S1 and
S2 in alternating sequence once per 7.5 seconds, so that each input was stimulated
with paired pulses each 15 seconds.
Control protocol for isolated and mixed EPSCs is as follows. Recordings were
conducted in voltage-clamp mode with holding potential at -50mV. Pharmacologically
isolated AMPA EPSCs were recorded under 5µM picrotoxin (PTX; Sigma, St. Louis MO,
USA) and D-(--)-2-amino-5-phosphonopentoic acid (APV 20µM; Tocris, Bristol, UK).
Picrotoxin was dissolved in the ACSF directly. APV (Tocris, Bristol, UK) was dissolved
in water to a 50mM stock before being added to ACSF. Pharmacologically isolated
NMDA EPSCs were recorded under 5µM PTX (Sigma, St. Louis MO, USA) and 6,7dinitroquinoxaline-2,3(1H,4H)-dione (DNQX 10µM; Sigma, St. Louis MO, USA). DNQX
(Sigma, St. Louis MO, USA) was dissolved in water to a 5mM stock before being added
to ACSF. Mixed currents were recorded with 2-100µM PTX (Sigma, St. Louis MO,
USA), 1mM glycine, and 1nM tetrodotoxin (TTX; Tocris, Bristol UK). Following control
protocol, 20µM Adenosine (Sigma, St. Louis MO, USA) was applied to the bath and
evoked EPSCs were recorded. Adenosine (Sigma, St. Louis MO, USA) was dissolved in
ACSF to a 1mM stock before being applied to the bath. Control solution was then used
to wash ADO from the bath and evoked EPSCs were recorded. The identity of all
evoked EPSCs were confirmed using selective antagonists APV and DNQX. After
recordings were conducted at -50mV, the holding potential was varied to determine
current-voltage relationship at -30, -40, -60, -70, and -80mV. In addition, depolarized

18

holding potentials (-30 and -40mV) allowed us to determine if EPSCs were
contaminated with inhibitory currents. Only currents that were still depolarizing at these
holding potentials were considered excitatory and included in the analysis.
Data analysis
Using custom-written programs in MatLab (© The MathWorks, Natick MA, USA),
EPSC amplitudes were measured as the difference between the mean membrane
potential during two or three measurement windows. The amplitude of EPSCs was
determined by placing a baseline window before the onset of an event and a
measurement window at the peak of the EPSC. For mixed current experiments the
baseline window was placed in the same manner as stated before. The AMPA window
was set at the fast onset peak and the NMDA window was set when an event returned
to baseline under APV (a selective NMDA antagonist; Fig. 2B). All inputs included in the
analysis fulfilled the criteria of (1) stability of EPSC amplitude during the control period,
(2) stability of the onset latency and kinetics of the slope of the EPSC, (3) absence of
inhibitory currents when the holding potential was depolarized to -30 and -40mV during
APV and DNQX conditions (Fig. 2B). Measurement windows for paired pulse
stimulation paradigm were the same duration but displaced by the inter-pulse interval
(50 ms).
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Statistical tests were conducted using a Student’s t-test, repeated measures
ANOVA, or univariate ANOVA with post-hoc comparisons (Bonferroni). Error bars
represent the standard error of the mean.
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Results
The experiments that follow aim to elucidate whether NMDA-mediated currents
are suppressed differentially from AMPA-mediated currents in layer 2/3 of rat visual
cortex. In order to accomplish this, we conducted experiments that systematically
isolated different components of excitatory postsynaptic currents. We investigated the
effect of adenosine on pharmacologically isolated AMPA and NMDA-mediated currents.
In these experiments, we demonstrate a similar reduction in EPSC amplitude
concurrent with an increase in the paired pulse ratio (suggesting a presynaptic action).
In addition, the voltage-dependence of the evoked AMPA and NMDA-mediated currents
further corroborates their identity. In our final preparation, we measured the effect of
adenosine on co-occurring AMPA- and NMDA-mediated components in which the
NMDA/AMPA ratio was maintained.
Adenosine reduces the amplitude of pharmacologically isolated AMPA currents
To study the effects of adenosine in layer 2/3 pyramidal neurons on AMPAmediated currents we recorded EPSCs evoked by a paired-pulse stimulus under the
background of a selective NMDA-antagonist (APV) and GABAA antagonist (PTX; Fig.
3A and Fig. 3B). After recording 80-100 sweeps to establish a stable baseline, 20µM
adenosine (ADO) was washed into the bath (Fig. 3A and Fig. 3B). It was assumed that
ADO concentrations in the bath reached 20µM after approximately 5 minutes of wash in
(Fig. 3B). The concentration of adenosine that robustly reduced the amplitude of
excitatory potentials (20µM) was established by previous experiments conducted by our
laboratory (N. Bannon et al., 2014). Adenosine was subsequently washed out of the
bath using control solution for approximately 5 minutes (Fig. 3B). After washout, DNQX
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was washed into the bath to both confirm the identity of the EPSC as an AMPAmediated event and to determine a potential inhibitory current contamination. All inputs
with inhibitory events were not included in our data set.
Under the application of adenosine, AMPA-mediated EPSCs were potently
reduced to 51.1 ± 4.59% of baseline (Fig. 3C; p<0.001). During washout of adenosine,
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the AMPA-mediated EPSC returned to 108 ± 20.7% of baseline (Fig. 3C; n.s). The bath
application of DNQX, a selective AMPA-antagonist, reduced the AMPA-mediated EPSC
to 4.31 ± 2.43% of baseline (Fig. 3C; p<0.001). Concurrently, we observed a modest
increase in the paired-pulse ratio (PPR) under bath application of adenosine (Fig. 4A;
p=0.067). An increase in PPR is commonly interpreted as a decrease in release
probability (Stevens, 1993) thus suggesting a presynaptic mechanism of ADO
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modulation. At differing holding potentials (-80, -70, -60, -50, -40, and -30 mV) a clear
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voltage-dependent relationship was seen during all conditions (Fig. 4B).
Adenosine reduces the amplitude of pharmacologically isolated NMDA currents
The effects of adenosine in layer 2/3 pyramidal neurons on NMDA-mediated
currents were studied by pharmacologically isolating NMDA currents with DNQX and
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PTX in control solution and subsequent bath application of adenosine. Similar to AMPAmediated currents, adenosine robustly reduced the amplitude of NMDA-mediated
EPSCs to 44.5 ± 4.94% of baseline (Fig 5C; p<0.001). During the washout of
adenosine, NMDA-mediated EPSCs returned to 101 ± 10.5% of baseline (Fig. 5C; n.s).
Wash-in of the selective NMDA-antagonist (APV) reduced NMDA-mediated EPSCs to
8.83 ± 4.55% of baseline (Fig. 5C; p<0.001). We observed a significant increase in the
paired-pulse ratio to 142 ± 17.3% of baseline (Fig. 6A; p=0.001) suggesting a reduction
in release probability and therefore a presynaptic action of adenosine. In addition, we
observed a characteristic voltage-dependent relationship of the NMDA receptor at
holding potentials between -30 and -80mV, where holding potentials less than -50mV
passed little current due to a Mg2+ ion obstructing the channel (Fig. 6B; Nowak et al.,
1984). It is important to note that our results show a clear difference in the voltage
dependence of AMPA-mediated (Fig. 4B) and NMDA-mediated currents (Fig. 6B).
These results indicate that we are truly recording isolated AMPA- and NMDA-mediated
currents. Our results show similar voltage dependent relationships that have been
previously identified for NMDA and non-NMDA-mediated currents (Klishin et al., 1995).

Adenosine reduces the amplitudes of mixed NMDA and AMPA currents proportionally
To study the effect of adenosine in layer 2/3 pyramidal neurons on mixed, AMPA
and NMDA-mediated, currents we recorded EPSCs evoked by a single pulse under the
background of PTX, TTX, and NMDAR co-activator glycine. A single pulse paradigm
was used in conjunction with a low concentration of PTX (2µM) and TTX (1nM) to
reduce slice seizures. Once a stable baseline was recorded (80-100 sweeps or
approximately 10mins), 20µM ADO was washed into the bath (Fig. 7B and Fig.7C).
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ADO was allowed to fully wash in (5mins) and the last 20 sweeps were averaged for
analysis (Fig. 7B and Fig. 7C). ADO was subsequently washed out of the bath (10mins;
Fig. 7B and Fig. 7C). After washout, 20µM APV was washed into the bath to isolate
AMPA-mediated currents (Figure 7C). This allowed us to determine appropriate
placement of NMDA-mediated measurement windows (see Methods). DNQX, a
selective AMPA antagonist, was washed into the bath at the end of the experiment to
confirm the absence of inhibitory currents at all holding potentials (-30 through -80mV;
not shown).
During bath application of adenosine, we observed a reduction in the amplitude
of both AMPA-mediated (Fig. 8A, 37.8 ± 5.92% of baseline; p<0.001) and NMDAmediated (Fig. 8A, 35.7 ± 8.91% of baseline; p<0.001) components of EPSCs. The
effects of adenosine could be reversed during washout where the AMPA and NMDA
components returned to 80.1 ± 5.79% (p=0.079) and 86.3 ± 7.19% (p=0.778) of
baseline, respectively (Fig. 8A). The application of the NMDA-antagonist, APV, reduced
NMDA-mediated currents to 14.8 ± 5.05% of baseline (Fig. 8A; p<0.001). When
compared, the mean amplitudes of AMPA or NMDA-mediated EPSCs under adenosine
were not statistically different from each other (Fig. 8A, T-test; p=0.157). When a ratio
was made of NMDA to AMPA-mediated EPSCs there was no significant difference
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between control and the wash-in of adenosine (Fig. 8B, T-test; p=0.644). Furthermore,
when the amplitudes of isolated AMPA and NMDA-currents under adenosine were

29

compared there was no statistical difference (not shown, T-test; p=0.338).
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Discussion
In accord with previous work from our lab, adenosine robustly reduced the
amplitude of EPSCs in L2/3 of rat visual cortex (N. Bannon et al., 2014). However, it
was not previously known whether adenosine worked preferentially on NMDA-mediated
or AMPA-mediated currents in the cortex. In dopamine neurons of the rat midbrain,
adenosine via activation of presynaptic A1Rs reduced NMDA-mediated currents 20
times more potently than AMPA-mediated currents (Y.-N. Wu et al., 1999). Their
proposed mechanism suggests that the majority of NMDAR activation is due to
glutamate spillover therefore a dilute concentration of glutamate would preferentially
reduce NMDA-mediated events (Y.-N. Wu et al., 1999). In contrast, work conducted in
the hippocampus has shown that AMPA and NMDA-mediated events are reduced
equally by adenosine (Garaschuk et al., 1992; Perkel & Nicoll, 1993) and increases in
release probability change NMDA/AMPA-mediated events proportionally (Tong & Jahr,
1994).
In our experiments we demonstrate that NMDA- and AMPA-mediated currents
are reduced proportionally in mixed current recordings of L2/3 rat visual cortex (Fig. 8a).
Thus, the NMDA/AMPA ratio was maintained during wash-in of adenosine (Fig. 8b). In
our pharmacologically isolated preparations, we observe an increase in the paired-pulse
ratio (EPSC2/EPSC1) which is inversely related to release probability (Stevens, 1993;
Fig. 4a and Fig. 6a). This result suggests that adenosine may be acting on A 1Rs thus
reducing the amount of glutamate released. Therefore, adenosine did not confer with a
selective reduction in NMDA-mediated currents (Fig. 8a).
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The implications of our findings reach beyond a fundamental understanding of
adenosine’s role in synaptic transmission in the visual cortex. A1R activation during the
induction of plasticity has been demonstrated to have long term effects on synaptic
transmission. In CA1 region of the hippocampus, long-term potentiation (LTP) was
nearly blocked by an adenosine analog, 2-chloroadenosine (CADO). Further studies
have shown that adenosine itself may block LTP induction and antagonizing the A 1
receptor using 8-cylcopentyl-1,3-dipropylxanthine (DPCPX) prevents adenosinemediated inhibition of LTP (De Mendonça & Ribeiro, 2001). A plausible mechanism for
the effect of adenosine on preventing LTP could be a reduction in the amount of
activated NMDARs. LTP requires an influx of Ca2+ through the NMDA receptor. NMDA
currents were inhibited by CADO in pyramids of dissociated hippocampus (de
Mendonça, Sebastião, & Ribeiro, 1995). In CA1-CA3 regions of the hippocampus, A1
antagonist, CPT, was shown to increase NMDA-mediated but not AMPA-mediated
currents (Klishin et al., 1995). This potential preference for modulation of NMDAmediated currents could be explained by phosphorylation of NMDA receptor subunits
downstream of protein kinase A activation via adenosine receptors (Chen & Roche,
2007).
Previous work from our lab has demonstrated that adenosine may serve a
homeostatic role in regulation of synaptic plasticity. The Hebbian model of learning
generally states that synapses activated before postsynaptic firing will be potentiated
(Magee & Johnston, 1997). Hence the common interpretation, ‘synapses that fire
together, wire together’. However, Hebbain-type long-term plasticity creates a positive
feedback loop that cannot explain the variability of synaptic weights (N. M. Bannon et
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al., 2016). In layer 2/3 of rat visual cortex, synapses are modulated at homosynaptic
(active) as well as heterosynaptic (non-active) inputs (Maxim Volgushev et al., 2016).
Furthermore, heterosynaptic inputs were modulated by the same activity as
homosynaptic inputs. The direction of change was weight-dependent so that overall
synaptic input was preserved (Maxim Volgushev et al., 2016). Recent experiments have
demonstrated that in L2/3 of rat visual cortex, adenosine strengthened weightdependent plasticity whereas adenosine antagonists prevent it (N. M. Bannon et al.,
2016).
The present study adds to the narrative of adenosine’s role in modulation of
plasticity. Here, we demonstrate that NMDA-mediated currents are not preferentially
reduced by adenosine in L2/3 pyramids of visual cortex. Thus, activation of adenosine
receptors and postsynaptic modulation of NMDA-mediated currents are likely not
mediating the effects of adenosine on weight-dependent plasticity.
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